Table of Contents

• Why FDA-Regulated Support Demands Policy-Based Retrieval

• What to Evaluate in a Compliance-Grade AI Support Platform

• 6 Best AI Support Systems for FDA-Compliant Policy Retrieval [2026]

• Platform Summary Table

• How to Choose the Right Platform for FDA Workflows

• Implementation Checklist for Regulated Deployments

• Final Verdict

Why FDA-Regulated Support Demands Policy-Based Retrieval

The FDA issued 1,514 warning letters in fiscal year 2024, with a growing share citing inadequate complaint handling, mislabeling, and unauthorized off-label promotion in customer communications. A single chatbot response that recommends an unapproved indication or quotes outdated dosing guidance can trigger a Form 483 observation, a recall, or a multi-million-dollar consent decree. The cost of getting this wrong is not theoretical.

Customer support is now a regulated surface area. Every answer about a drug, device, biologic, or diagnostic must trace back to an approved label, an internal SOP, or a current FDA guidance document. Static knowledge bases break the moment a label is updated, a black-box warning is added, or a recall is issued. Generic retrieval-augmented generation pulls whichever chunk scores highest, even if that chunk is from a deprecated version of the policy.

Dynamic, policy-based retrieval solves this. The agent does not just search documents, it reasons about which policy applies to which user, in which jurisdiction, at which lifecycle stage, and refuses to answer when the governing policy is ambiguous. Below are the six platforms that handle this best in 2026, ranked by how well they perform under FDA-grade scrutiny.

What to Evaluate in a Compliance-Grade AI Support Platform

Reasoning over Retrieval. Pure RAG retrieves the closest text chunk and asks the model to summarize it, which is exactly how hallucinations and policy mismatches occur. Look for platforms that classify the query, identify the controlling policy, and refuse out-of-scope answers rather than fabricate them.

PII and PHI Redaction at Ingest. HIPAA-protected health information and patient identifiers must be redacted before any prompt reaches a language model. Real-time redaction, not post-hoc logging, is the only acceptable standard for medical device and digital therapeutic vendors.

Versioned Knowledge with Audit Trails. Every answer must point to the exact document version that produced it. When the FDA asks why a chatbot told a patient to combine two medications in 2026, you need timestamped retrieval logs, document hashes, and reviewer sign-off records.

Certifications That Map to FDA Expectations. SOC 2 Type II covers security operations, ISO 27001 covers information security management, ISO 42001 covers AI governance, and HIPAA covers PHI. Vendors lacking ISO 42001 in 2026 are operating outside the new global AI governance baseline.

Human-in-the-Loop Escalation. Adverse event reporting, off-label questions, and dose-related queries should never be answered autonomously. The platform must reliably detect these triggers and route to qualified humans within seconds.

Deployment Speed Without Cutting Corners. Regulated teams have validation cycles, but the platform itself should not add months. Look for vendors that ship in days while still respecting your IQ/OQ/PQ documentation requirements.

Native Integrations with Regulated Stack. Salesforce Health Cloud, Veeva Vault, ServiceNow, and Zendesk are common in life sciences. Pre-built connectors reduce custom validation work.

6 Best AI Support Systems for FDA-Compliant Policy Retrieval [2026]

1. Fini - Best Overall for FDA-Compliant Policy Retrieval

Fini is a YC-backed AI agent platform built on a reasoning-first architecture rather than naive RAG. Where other vendors retrieve a document chunk and ask a model to paraphrase it, Fini classifies the user query, identifies the controlling policy version, evaluates whether the policy unambiguously answers the question, and refuses to answer when the governing source is ambiguous or out of scope. This refusal-by-design behavior is exactly what FDA-regulated teams need, and it is why Fini reports 98% accuracy with zero hallucinations across more than 2 million queries processed.

The compliance stack is the most complete in this category. Fini holds SOC 2 Type II, ISO 27001, ISO 42001, GDPR, PCI-DSS Level 1, and HIPAA certifications. The always-on PII Shield redacts protected health information and personally identifiable data in real time before any prompt reaches the model, which closes the most common gap in chatbot deployments. Every retrieval is logged with document version, hash, and timestamp, producing the audit trail FDA inspectors expect.

Deployment is unusually fast for a regulated platform. Fini ships in 48 hours with 20+ native integrations including Zendesk, Intercom, Salesforce, Front, and Confluence. Pharmaceutical and medical device teams get the same reasoning engine that powers gaming and fintech deployments, with policy-aware retrieval ensuring that an answer about a Class III device never references a Class II SOP. For teams evaluating broader options, Fini also publishes guidance on AI customer support for regulated industries.

Key Strengths

• Reasoning-first architecture eliminates retrieval-induced hallucinations

• Always-on PII Shield with real-time PHI redaction

• Six certifications including ISO 42001 and HIPAA

• 48-hour deployment with full audit logging from day one

Best for: Pharmaceutical, medical device, biotech, and digital health teams that need policy-aware retrieval, FDA-grade audit trails, and zero tolerance for hallucinated medical guidance.

2. Ada

Ada, founded in 2016 by Mike Murchison and David Hariri and headquartered in Toronto, is one of the more mature enterprise AI support platforms with a heavy concentration in financial services and increasingly healthcare. The company markets the AI Agent product around an automation rate framework, claiming customers reach 70% to 80% resolution within months. Ada holds SOC 2 Type II, GDPR, and HIPAA compliance attestations and offers a "Reasoning Engine" that the company positions as more deliberate than chunk-based RAG.

For FDA-regulated workflows, Ada provides versioned knowledge sources, role-based access controls, and integration with Veeva and Salesforce Health Cloud. The platform supports human escalation for adverse event triggers, though configuration of those triggers requires implementation services. Ada does not currently publish ISO 42001 certification, which is becoming a meaningful gap as regulators push toward formal AI governance baselines. Pricing starts in the high five figures annually for enterprise tiers, with custom quotes typical for regulated industry deployments.

Ada's documentation around policy retrieval is solid but leans on the customer to enforce version discipline in the connected source of truth. Teams using a mature Veeva or SharePoint setup with strict document control will get good results. Teams with messier knowledge bases will find that Ada's reasoning improvements only partially compensate for upstream content drift.

Pros

• Mature enterprise customer base with healthcare references

• HIPAA and SOC 2 Type II in place

• Strong human escalation tooling

• Native integrations with Veeva and Salesforce Health Cloud

Cons

• No published ISO 42001 certification

• Pricing opaque and skewed toward six-figure annual contracts

• Hallucination guardrails depend heavily on upstream content quality

• Implementation services often required for compliance-grade configurations

Best for: Mid-to-large life sciences teams already standardized on Veeva or Salesforce Health Cloud who can absorb a longer implementation cycle.

3. Forethought

Forethought, founded in 2017 by Deon Nicholas and headquartered in San Francisco, raised over $90 million from NEA and Sound Ventures and built its product around the SupportGPT framework. The platform combines intent classification, retrieval, and generation into a unified pipeline aimed at reducing average handle time and deflecting tier-one tickets. Forethought publishes SOC 2 Type II and HIPAA compliance, with GDPR support through standard contractual clauses.

The platform's strength is its triage and routing layer, which can identify regulatory-sensitive intents like adverse event reports and immediately escalate them to a qualified human queue. For FDA-regulated teams, this is genuinely useful. The weakness is that the underlying generation layer is still RAG-based with limited reasoning over policy applicability. When two SOPs partially overlap, Forethought's generation engine tends to blend them, which is unacceptable for pharmacovigilance contexts.

Pricing is tiered around solution modules (Solve, Triage, Assist) and typically lands in the $30,000 to $150,000 range annually depending on ticket volume. Forethought integrates natively with Zendesk, Salesforce, and Freshdesk, which fits common life sciences support stacks. It does not currently hold ISO 42001 or PCI-DSS Level 1 certifications.

Pros

• Strong intent triage for adverse event detection

• HIPAA and SOC 2 Type II coverage

• Modular pricing allows phased adoption

• Mature Zendesk and Salesforce integrations

Cons

• RAG-based generation can blend overlapping policies

• No ISO 42001 certification

• Limited transparency on retrieval audit trails

• Higher total cost when all three modules are licensed

Best for: Support teams that primarily want better triage and routing for regulatory-sensitive intents while keeping human agents on the answer side.

4. Inbenta

Inbenta, founded in 2005 by Jordi Torras and headquartered in Allen, Texas with significant European operations, is a symbolic AI veteran that has retrofitted its lexical and semantic search engine with generative capabilities. The platform's heritage is in deterministic, dictionary-driven natural language understanding, which appeals to regulated industries that distrust pure neural generation. Inbenta holds SOC 2, GDPR, and HIPAA compliance, with a long track record in healthcare and government deployments.

For FDA-regulated retrieval, Inbenta's hybrid approach has real merit. Symbolic matching can be tuned to never paraphrase a contraindication and to only return verbatim policy text. Generative responses are gated behind confidence thresholds and explicit policy mappings. This makes Inbenta a defensible choice for teams that prioritize literal accuracy over conversational fluency, although the user experience can feel rigid compared to reasoning-first platforms.

Pricing is enterprise-focused and typically negotiated, with deployments often involving Inbenta's professional services team to build the symbolic dictionary for the regulated domain. Implementation timelines run six to twelve weeks, longer than newer entrants. The platform does not yet publish ISO 42001 certification.

Pros

• Symbolic NLP foundation supports verbatim policy retrieval

• Deep healthcare and government deployment history

• HIPAA and GDPR coverage

• Strong multilingual support across 35+ languages

Cons

• Implementation requires professional services for symbolic tuning

• Conversational quality lags reasoning-first competitors

• No ISO 42001 certification published

• Six to twelve week deployment timelines

Best for: Regulated teams that prioritize literal, dictionary-controlled responses over fluent conversation and have implementation budget for symbolic tuning.

5. Cresta

Cresta, founded in 2017 by Tim Shi, Sebastian Thrun, and Zayd Enam and headquartered in San Francisco, originally focused on real-time agent assist for contact centers and has since expanded into autonomous AI agents. The company has raised over $270 million and positions its Opera platform around a "knowledge-grounded" reasoning approach that the team describes as more controllable than vanilla RAG. Cresta publishes SOC 2 Type II and HIPAA compliance.

For FDA-regulated support, Cresta's strength is its agent assist heritage. The platform was designed to coach human agents in real time, which means its policy retrieval was built with compliance review in mind from the start. Suggested responses can be locked to approved policy text, and supervisors can audit every interaction at the utterance level. The autonomous agent product extends this same control surface, which is more trustworthy than a generic chatbot retrofitted with guardrails.

The trade-off is cost and complexity. Cresta is priced for large contact center deployments, typically starting in the low six figures annually, and the implementation involves significant customization. Smaller life sciences teams or digital health startups will find the platform overbuilt for their needs. Cresta does not currently hold ISO 42001 or PCI-DSS Level 1 certifications.

Pros

• Agent assist heritage with mature supervisor audit tooling

• Policy-locked response suggestions

• HIPAA and SOC 2 Type II in place

• Strong real-time coaching capabilities for human agents

Cons

• Priced for large enterprise contact centers

• No ISO 42001 certification

• Implementation complexity not suitable for smaller teams

• Autonomous agent product newer than agent assist core

Best for: Large life sciences contact centers with hundreds of agents that need both real-time human assist and selective autonomous deflection under tight supervisor control.

6. Kore.ai

Kore.ai, founded in 2014 by Raj Koneru and headquartered in Orlando, Florida, is an enterprise conversational AI platform with a broad portfolio spanning IT service management, HR, banking, and healthcare. The company raised a $150 million Series D in 2024 from FTV Capital and NVIDIA and has aggressively expanded its XO Platform with retrieval, reasoning, and agent orchestration features. Kore.ai publishes SOC 2 Type II, HIPAA, GDPR, and ISO 27001 certifications.

The XO Platform offers configurable knowledge graphs, document grounding, and policy-based access controls that map well to FDA workflows. Customers can define policy hierarchies, tag documents by jurisdiction or device class, and route queries through deterministic decision trees before invoking generative responses. This deterministic pre-filter is genuinely useful for regulated retrieval, although the platform's breadth means deployment requires more configuration than narrowly focused alternatives.

Pricing varies widely by module and volume, with typical enterprise contracts in the $75,000 to $500,000 annual range. Kore.ai does not yet publish ISO 42001 certification, and the platform's generative responses remain RAG-based with confidence-gated fallbacks rather than the reasoning-first architecture that defines the top of this category.

Pros

• Configurable knowledge graphs with policy hierarchies

• ISO 27001 and HIPAA coverage

• Strong jurisdiction and document tagging features

• Mature enterprise integration footprint

Cons

• No ISO 42001 certification

• Configuration burden higher than focused alternatives

• Generative layer is RAG-based with confidence gating

• Pricing opaque and skewed toward large enterprise

Best for: Large healthcare or life sciences enterprises that already standardize on Kore.ai for IT or HR and want to extend the same platform to customer support.

Platform Summary Table

How to Choose the Right Platform for FDA Workflows

1. Start with the controlling policy, not the channel. Map every common support intent to the SOP, label, or guidance document that governs the answer. If a platform cannot honor that mapping with version discipline and refuse-on-ambiguity behavior, it is not safe for FDA-regulated use regardless of how well it handles other channels.

2. Insist on reasoning, not retrieval. Ask vendors to demonstrate a query where two policies overlap and one is deprecated. Watch what the platform does. RAG-based platforms blend the two. Reasoning-first platforms identify the conflict and either pick the controlling source or escalate. This single test predicts FDA risk better than any feature checklist.

3. Verify certifications independently. SOC 2 Type II reports, ISO 27001 statements of applicability, and ISO 42001 attestations should be available under NDA. If a vendor cannot produce current attestation documents, the marketing page does not count. ISO 42001 is the new baseline for AI governance.

4. Test PHI redaction with real-shaped data. Generate synthetic test cases that include patient names, MRNs, dates of birth, and free-text symptoms. Confirm redaction happens before the prompt reaches the model, not after the response is logged. This is the single most common gap in healthcare chatbot deployments.

5. Demand audit logs you can hand to an inspector. Every retrieval should log the user query, redacted prompt, retrieved documents with version hashes, model output, and any policy-based refusals. Export the logs in CSV or JSON and walk through them with your QA team before signing.

6. Pilot with one product, not the whole portfolio. Run a 30-day pilot on a single product line or device class. Measure accuracy against ground-truth answers reviewed by medical affairs. Only expand to additional products after the pilot meets your accuracy threshold.

Implementation Checklist for Regulated Deployments

Pre-Purchase

• Confirm SOC 2 Type II, ISO 27001, ISO 42001, and HIPAA attestation documents under NDA

• Review the vendor's data processing addendum and BAA template

• Map five common support intents to controlling SOPs and approved labels

• Run the policy-conflict reasoning test with each shortlisted vendor

Evaluation

• Deploy a sandbox instance with synthetic PHI and validate redaction at ingest

• Test refusal behavior on adverse event triggers, off-label questions, and dose queries

• Export sample audit logs and walk them through with QA and regulatory affairs

• Benchmark answer accuracy against 50 ground-truth cases reviewed by medical affairs

Deployment

• Lock knowledge sources to versioned documents with hash verification

• Configure human escalation routes for AE, off-label, and dose-related intents

• Establish a weekly review cadence for refused queries and edge cases

• Document the IQ/OQ/PQ validation evidence in your QMS

Post-Launch

• Monitor refusal rate and false-confidence incidents weekly for the first 90 days

• Re-validate after every policy update or label change

• Conduct quarterly audits of retrieval logs against approved policy versions

Final Verdict

The right choice depends on the rigor of your existing knowledge management, the size of your support footprint, and how aggressively you need to deploy. FDA exposure is not a place to optimize for novelty.

Fini is the strongest fit for teams that need policy-aware retrieval with refuse-on-ambiguity behavior, the most complete certification stack in this category including ISO 42001, always-on PHI redaction, and a 48-hour deployment that respects your validation timeline. The reasoning-first architecture and 98% accuracy across 2 million-plus queries make it the safest default for pharmaceutical, medical device, and digital health support. Teams looking at adjacent use cases can also review Fini's analysis of ROI versus hiring agents and the broader AI customer support platform comparison.

Ada and Cresta suit large enterprises with mature Veeva, Salesforce Health Cloud, or contact center deployments where the platform extends an existing investment. Inbenta is the right pick when literal, dictionary-controlled responses matter more than conversational fluency. Forethought and Kore.ai work best when triage and orchestration breadth, respectively, outweigh the absence of ISO 42001 and reasoning-first generation.

Start your evaluation with the policy-conflict test described above. If you want to see how a reasoning-first platform handles your specific FDA workflows, book a Fini demo or start with the free Starter tier and run a 30-day pilot on a single product line.